YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Therapeutic Anti-inflammatory Effect of Ginkgo Terpene on Arthritis due to Candida albicans

Ginkgo Terpene의 Candidate albicans로 인한 관절염에 대한 치료효과

  • 이순현 (동덕여자대학교 약학대학 면역. 미생물학 교실) ;
  • 이주희 (동덕여자대학교 약학대학 면역. 미생물학 교실) ;
  • 한용문 (동덕여자대학교 약학대학 면역. 미생물학 교실)
  • Published : 2005.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Candida albicans, a polymorphic fungus, causes systemic and local infections. Recent reports show that the fungus is a main etiological agent for the arthritis. For trea tment, antifungal drugs and/or rheumatoid drugs are used, but resistance and side effects limit application of the drugs. In search of new sources for treatment of the fungal arthritis, we choose Egb 761 (extract of Ginkgo leaves 761), one of the most popular over-the-counter herbal medicines. The Egb 761 contains two major ingredients such as terpene and flavonoid. In the present study, we examined if the terpene portion of Egb 761 had anti-inflammatory activity against C.albicans-caused arthritis. The terpene was extracted with combination of methanol and water from the Egb 761, followed by gel-permeation chromatography. Presence of terpene was determined by the Salkowski colorimetric method and HPLC analysis. For an animal model of inflammation induction, mice were given an emulsion form of C.albicans cell wall mixed with Complete Freund's Adjuvant (CFA) by footpad-injection. Results showed that intraperitoneal administration of the water-soluble portion that contained terpene and flavonoid reduced the inflammation. Whereas the terpene had anti-inflammatory activity, flavonoid portion had no such activity, For determination of possible mechanism of the activity, the terpene seemed to be suppression of nitric oxide (NO) production from LPS-treated macrophages. Taken together the Ginkgo terpene may have anti-inflammatory effect against C.albicans-caused arthritis, possibly by blocking NO production.

Keywords

References

  1. Cuende, E., Barbadillo, C. E., Mazzucchelli, R., Isasi, C., Trujillo, A. and Andreu, J. L. : Candida arthritis in adult patients who are not intravenous drug addicts: report of three cases and review of the literature. Semin Arthritis Rheum. 22, 224 (1993) https://doi.org/10.1016/0049-0172(93)80071-M
  2. Lerch, K, Kalteis, T., Schubert, T., Lehn, N. and Grifka, J. : Prosthetic joint infection with osteomyelitis due to Candida albicans. Mycoses. 46, 462 (2003) https://doi.org/10.1046/j.0933-7407.2003.00928.x
  3. Azaceta, G., Olave. T., de los Martires, L. D., Delgado, C, Gutierrez, M. and Palomera, L. : Successful lipid-complexed amphotericin B treatment of Candida arthritis in a lymphoma patient. Rev. Rhum. Engl. 66, 434 (1999)
  4. Choi, I. S., Kim, S. J., Kim, B. Y., Joh, J. W., Kim, Y. I., Lee, S. K., Huh, W. S., Oh, H. Y., Kim, D. J, Kim, Y. G., Kim, M. K., Ko, Y. H. and Lee, B. B. : Candida polyarthritis in a renal transplant patient: case report of a patient successfully treated with amphotericin B. Transplant Proc. 32, 1963 (2000)
  5. Turgut, B., Vural, O., Demir, M. and Kaldir, M. : Candida arthritis in a patient with chronic myelogenous leukemia (CML) in blastic transformation, unresponsive to fluconazole, but treated effectively with liposomal amphotericin B. Ann. Hematol. 81, 529 (2002) https://doi.org/10.1007/s00277-002-0503-2
  6. Lee, D. M. and Weinblatt, M. E. : Rheumatoid arthritis. Lancrt. 358, 903 (2001) https://doi.org/10.1016/S0140-6736(00)05272-7
  7. Felson, D. T., Anderson, J. J. and Meena, R. F. : Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis: a metaanalysis of published clinical trials. Arthritis Rheum. 35, 1117 (1992) https://doi.org/10.1002/art.1780351003
  8. Myers, L. K., Kang, A. H., Postlethwaite, A. E., Rosloniec, E. E, Morharn, S. G., Shlopov, B. V., Goorha, S. and Ballou, L. R. : The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum. 43, 2687 (2000) https://doi.org/10.1002/1529-0131(200012)43:12<2687::AID-ANR8>3.0.CO;2-9
  9. Bauer, H. and Marker-Hermann, E. : Therapy with nonsteroidal anti-inflammatory drugs. Orthopade. 32, 1088 (2003) https://doi.org/10.1007/s00132-003-0559-2
  10. Beek, T. A. : Chemical analysis of Ginkgo biloba leaves and extracts. J. Chromato. A 967, 21 (2002) https://doi.org/10.1016/S0021-9673(02)00172-3
  11. Maelennan, K. M., Darlington, C. L. and Smith, P. F. : The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog. Neurobiol. 67, 235 (2002) https://doi.org/10.1016/S0301-0082(02)00015-1
  12. DeFeudis, F. Y. : Ginkgo biloba Extract (EGb 761) : Pharmacological activities and Clinical Application. Elesevier 97, 135 (1991)
  13. Kobuchi, H., Droy-Lefaix, J., Christen, Y. and Packer, L. : Ginkgo biloba extract (EGb 761) inhibitory effect on nitric oxide production in the machrophage cell line Raw 264.7. Biochem. Pharmacol. 53, 897 (1997) https://doi.org/10.1016/S0006-2952(96)00873-8
  14. Logani, S., Chen, M. C., Tran, T., Le, T. and Raffa, R. B. : Action of Ginkgo biloba related to potential for the treatment of conditions involving cerebral hypoxia. Life Sciences 1389 (2000)
  15. Hu, L., Chen, Z., Cheng, X. and Xie, Y. : Chemistry of ginkgolides: structure-activity relationship as PAF antagonists. Pure. Appl. Chem, 71, 1153 (1999) https://doi.org/10.1351/pac199971061153
  16. Nishida, S. and Satoh, H. : Comparative vasodilating action among terpenoids and flavonoids contained in Ginkgo biloba extract. Clinica. Chimica Acta 339, 129 (2004) https://doi.org/10.1016/j.cccn.2003.10.004
  17. Braquet, P. and Hosford, D. : Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents. J. Ethnopharmacol. 32, 135 (1991) https://doi.org/10.1016/0378-8741(91)90111-P
  18. Zhao, H. W. and Li, X. Y. : Ginkgolide A, B, and huperzine A inhibit nitric oxide-induced neprotoxicity. Int. Immunopharmacol. 2, 1551 (2002) https://doi.org/10.1016/S1567-5769(02)00093-0
  19. Han, Y. and Cutler, J. E. : Antibody response that protects against disseminated candidiasis. Infect Immun. 63, 2714 (1995)
  20. Han, Y., Kozel, T. R., Zhang, M. X., MacGill, R. S., Carroll, M. C. and Cutler, J. E. : Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis. J. Immunol. 167, 1550 (2001) https://doi.org/10.4049/jimmunol.167.3.1550
  21. Han, Y., Ulrich, M. A. and Cutler, J. E. : Candida albicans mannan extract -protein conjugates induce a protective immune response against experimental candidiasis. J. Infect. Dis. 179, 1477 (1999) https://doi.org/10.1086/314779
  22. Lee, S. and Han, Y. : Isolation and analysis of ginkgolides compound from EGb 761. Dongduk Pharm. Res. 7, 39 (2003)
  23. Han, Y., Jin, B. S., Ko, S. K. and Lee, J. H. : Immunoactivity of ginsenosides Re and Rg1 enhances resistance of mice against experimental disseminated candidiasis. Nat. Prod. Sci. 10, 134 (2004)
  24. Li, W and Fitzloff, J. E ; Simultaneous determination of terpene lactones and flavonoid aglycones in Ginkgo biloba by highperformance liquid chromatography with evaporative light scattering detection. J. Pharm. Biomed. Anal. 30, 67 (2002) https://doi.org/10.1016/S0731-7085(02)00201-7
  25. Lotito, A. P., Muscara, M. N., Kiss, M. H., Teixeira, S. A., Novaes, G. S., Laurindo, I. M., Silva, C. A. and Mello, S. B. ; Nitric oxide-derived species in synovial fluid from patients with juvenile idiopathic arthritis. Rheumatol. 31, 992 (2004)
  26. Nissler, K., Pohlers, D., Huckel, M., Simon, J., Brauer, R. and Kinne, R. W. : Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation. Ann. Rheum. Dis. 63, 1470 (2004). https://doi.org/10.1136/ard.2003.013060
  27. Kinne, R. W, Brauer; R., Stuhlmuller; B., Palombo-kinne, E. and Burmester, G.-R. : Macrophages in rheumatoid arthritis. Arthritis Res. 2, 189 (2000) https://doi.org/10.1186/ar86